MedTrace Logo

Topical Cosmetic Products for Hand and Foot Syndrome

NCT06586073 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 53

Last updated 2024-09-19

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of a dermocosmetic protocol in reducing the main cutaneous side effects that occur in palmar-plantar erythrodysesthesia syndrome in subjects with a tumor diagnosis, undergoing chemotherapy and targeted treatments such as target therapy and radiotherapy.

Conditions

  • Hand Foot Skin Syndrome

Interventions

OTHER

cosmetic products

All patients enrolled were prescribed four cosmetic products (Ontherapy® by Dermophisiologique) for skin treatment: a cleansing cream, a soothing and nourishing cream, an anti-desquamation cream with urea 5%, and an emollient mixture. Patients were instructed to use each product at home for 45 days, following a specific protocol: in the morning, apply the affinity cleansing cream during skin cleansing, followed by the anti-desquamation cream, while in the evening, apply affinity cleansing cream followed by the application of the emollient mixture and then the soothing and nourishing cream.

Sponsors & Collaborators

  • European Institute of Oncology

    collaborator OTHER

  • Dermophisiologique s.r.l

    lead INDUSTRY

Principal Investigators

  • Ida Minchella · European Institute of Oncology

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-08-31
Primary Completion
2023-11-30
Completion
2023-11-30

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06586073 on ClinicalTrials.gov